|
- 2016
MMP-9联合NT-proBNP在非ST段抬高急性冠脉综合征危险分层的研究
|
Abstract:
摘要:目的 探讨N末端脑钠肽(NT-proBNP)、基质金属蛋白酶-9(MMP-9)在非ST段抬高急性冠脉综合征(NSTE-ACS)危险分层、预后评估中的作用及相互关系。方法 连续收入因胸闷、胸痛至我院心内科住院的NSTE-ACS患者共114例,按照GRACE评分分为高危、中危、低危组,另设正常对照组58例,酶联免疫吸附法测定MMP-9浓度,电化学发光法测定NT-proBNP浓度,Gensini积分表示冠脉病变程度,并对主要不良心脏事件(MACE)的发生情况进行随访6个月。结果 ①MMP-9、lgNT-proBNP水平在各组间具有显著性差异(P<0.05);②ROC曲线分析显示lgNT-proBNP水平可预测NSTE-ACS随访期MACE,其曲线下面积为0.795,截断值2.069,相应NT-proBNP值为116.56ng/L;MMP-9水平可预测NSTE-ACS随访期MACE,其曲线下面积为0.696,截断值32.49ng/mL;2项指标均异常预测MACE的灵敏度为80.41%,特异度为82.19%,正确诊断指数为0.63。③Cox回归分析显示,MMP-9及NT-proBNP均异常与随访期MACE发生率独立相关,OR值为3.751。结论 MMP-9与NT-proBNP可以作为NSTE-ACS危险分层的血清学指标,二者联合应用可显著提高MACE的风险预测水平。
ABSTRACT: Objective To explore the role and relationship of N-terminal pro-brain natriuretic peptide (NT-proBNP) and matrix metalloproteinase-9 (MMP-9) in risk stratification and prognosis assessment of non-ST elevation acute coronary syndrome (NSTE-ACS). Methods We recruited 114 patients with NSTE-ACS and classified them into three groups according to the GRACE risk stratification: high-risk, intermediate-risk and low-risk groups. Another 58 patients were recruited as controls. Arterial blood was collected before angiography for the measurement of serum NT-proBNP and MMP-9. Gensini score was used to evaluate the degree of coronary artery stenosis. All the patients were followed up for 6 months and MACE was observed and recorded. Results ① The levels of lg NT-proBNP and MMP-9 significantly differed between the groups (P<0.05). ② ROC curve analysis showed that lg NT-proBNP could predict MACE of NSTE-ACS; area under the curve was 0.795, the cutoff value was 2.069, corresponding to the NT-proBNP value of 116.56 ng/L. MMP-9 could predict MACE of NSTE-ACS; area under the curve was 0.696, the cutoff value was 32.49 ng/ml; both of the abnormal indexes could predict MACE with the sensitivity of 80.41%, specificity of 82.19%, and Youden’s index of 0.63. ③ Cox regression analysis showed that abnormal MMP-9 and NT-proBNP levels were independently related to the incidence of MACE by the value of OR as 3.751. Conclusion MMP-9 and NT-proBNP may be used as serological indicators in risk stratification of NSTE-ACS. The combined use of NT-proBNP and MMP-9 increases the power of predicting MACE
[1] | 王绍欣,董平栓,杨旭明,等.急性冠状动脉综合征患者冠状动脉血及外周血血浆基质金属蛋白酶-9水平检测[J].郑州大学学报(医学版),2006, 41(6):1092-1094. |
[2] | RAMJANE K, LEI H, CHANG J, et al. The use of risk scores for stratification of non-ST elevation acute coronary syndrome patients[J]. Exp Clin Cardiol, 2009, 14(2):e25-e30. |
[3] | KRISHNA GA, UMESH UT, EVA KR, et al. Does simplicity compromise accuracy in ACS risk prediction? A retrospective analysis of the TIMI and GRACE risk scores[J]. PLoS One, 2009, 4(11):e7947. |
[4] | 赵晗,刘文娴. 非ST段抬高急性冠状动脉综合征患者血浆NT-ProBNP与GRACE危险分层的关系[J]. 心肺血管病杂志, 2011, 30(2):111-115. |
[5] | 韩琳,赵祥海,吴宜鸣.心功能Ⅲ、Ⅳ级慢性心衰患者血清CA125与NT Pro-BNP浓度相关性研究[J]. 川北医学院学报,2014, 29(5):489-491. |
[6] | AMSTERDAM EA, WENGER NK, BRINDIS RG, et al. 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes[J]. Circulation, 2014, 130(25):2354-2394. |
[7] | 张兆志,孟晓萍,王莉.急性冠脉综合征患者血清TNF-α、IFN-γ、MMP-9和oxLDL水平的检测及其临床意义[J]. 吉林大学学报(医学版),2011, 37(3):534-537. |
[8] | FUKUDA D, SHIMADA K, TANAKA A, et al. Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris[J]. Am J Cardiol, 2006, 97(2):175-180. |
[9] | CMCA BA, CANNON CP, SABATINE MS, et al. Concentrations of creative protein and B-type natriuretic peptide 30 days after acute coronary syndromes independently predict hospitalization for heart failure and cardiovascular death[J]. Clin Chem, 2009, 55(2):265-273. |
[10] | GUO CL, ZHANG SL, ZHANG JB, et al. Correlation between the severity of coronary artery lesions and levels of estrogen, hs-CRP and MMP-9[J]. Exp Ther Med, 2014, 7(5):1177-1180. |
[11] | 路艳,张春艳,王聪霞,等. 高糖对MMP-2与TIMP-2的表达及血管平滑肌细胞增殖的影响[J]. 西安交通大学学报(医学版), 2012, 33(3):312-315. |
[12] | GENSINI GG. A more meaningful scoring system for determining the severity of coronary heart disease[J]. Am J Cardiol, 1983, 51(3):1606. |
[13] | ROOBOTTOM C, MITCHELL G, IYENGAR S. The role of non-invasive imaging in patients with suspected acute coronary syndrome[J]. Br J Radiol, 2011, 84(3):S269-S279. |